4//SEC Filing
Hopkins Robert O 4
Accession 0001593968-20-002245
CIK 0000887247other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:26 PM ET
Size
5.3 KB
Accession
0001593968-20-002245
Insider Transaction Report
Form 4
Hopkins Robert O
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-11-20$0.41/sh−35,000$14,182→ 254,810 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were for the sole purpose of satisfying or paying income or withholding tax obligations of the undersigned.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4028 to $0.4076, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001461736
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:26 PM ET
- Size
- 5.3 KB